CA2254599A1 - Conversion of n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide acetate to n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide - Google Patents

Conversion of n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide acetate to n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide Download PDF

Info

Publication number
CA2254599A1
CA2254599A1 CA002254599A CA2254599A CA2254599A1 CA 2254599 A1 CA2254599 A1 CA 2254599A1 CA 002254599 A CA002254599 A CA 002254599A CA 2254599 A CA2254599 A CA 2254599A CA 2254599 A1 CA2254599 A1 CA 2254599A1
Authority
CA
Canada
Prior art keywords
hydroxy
methylethyl
fluorophenyl
acetamide
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002254599A
Other languages
French (fr)
Inventor
Vidyanatha A. Prasad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of CA2254599A1 publication Critical patent/CA2254599A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a process for converting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The process includes the step of hydrolyzing N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate with water or an aqueous alkali in the presence of an aprotic, aromatic solvent.

Description

CA 022~4~99 1998-11-27 1, .

Mo4699 CONVERSION OF N-(4-FLUOROPHENYL)-2-HYDROXY-N-(1-METHYLETHYL) ACETAMIDE ACETATE TO N-(4-FLUORO-PHENYL)-2-HYDROXY-N-(1-METHYLETHYL) ACETAMIDE
TECHNICAL FIELD OF THE INVENTION
The field of the present invention is the synthesis of hydroxy acetamides. More particularly, the invention relates to methods for producing N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide.
BACKGROUND OF THE INVENTION
Hydroxy acetamides are useful intermediates in the preparation of thiadiazole acetamide herbicides. An exemplary such herbicide is N-(4-fluorophenyl-N-(1 -methylethyl)-2-[[5-(trifluoromethyl-1,3,4-thiadiazole-2-yl]oxy]acetar"ide. (See, e.g., U.S. Patent 5,101,034). This thiadiazole acetamide can be made by reacting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide with 2-methylsulfonyl-5-trifluoromethyl-1,3,4-thiadiazole (See, e.g., U.S. Patent 5,101,034). Typically, formation of the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide is accomplished by converting the corresponding chloride (i.e., [2-chloro-N-(4-fluoro-phenyl)-N-(1 -methylethyl)aceta, l ,ide]) to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate and then hydrolyzing the acetate intermediate to the final hydroxy acetamide using an alcohol.
U.S. Patent 4,334,073 discloses the production of hydroxy-acetic acid-N-methylamide and hydroxy acetic acid-2-ethyl-piperidine. The methylamide compound is made by reacting chloroacetic acid-N-methylanilide in toluene with sodium acetate and benzylLli"~etl,yl-ammonium chloride to form acetoxy-acetic acid-N-methylanilide and then hydrolyzing that acetate intermediate with methanol to form hydroxy-acetic acid-N-methylamide. A by-product of that reaction, however, is methyl acetate, which must be removed by distillation. In a similar fashion, the piperidine compound is made by reacting chloroacetic acid-N-ethylpiperidine in toluene with sodium acetate and benzylLli",eLl,yl-CA 022~4~99 1998-11-27 Mo-4699 - 2 -ammonium chloride to form acetoxy-acetic acid-N-ethylpiperidine and then hydrolyzing that acetate intermediate with methanol to form hydroxy-acetic acid-N-ethylpiperidine. Methyl acetate is also formed as a by-product of that reaction and needs to be removed via distillation.
There is a need in the art, therefore, for a method to produce hydroxy acetamides such as N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide, which method avoids the formation of methyl acetate and thus, avoids the need for an additional distillation step.
BRIEF SUMMARY OF THE INVENTION
The present invention provides a process for making N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The process converts N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The process includes the step of reacting N-(4-fluorophenyl)-2-hydroxy-N-(1-methyl-15 ethyl)acetamide acetate with an alkali metal base in the presence of water and an aprotic, aromatic solvent.
The N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate used in the process is produced by reacting 2-chloro-N-(4-fluorophenyl)-N-(1-methylethyl)acetamide with sodium acetate. The 20 reaction of the acetate with base and water in the solvent produces a reaction product having an aqueous phase and an organic phase. The process can further include the step of recovering N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide from the organic phase.
Preferred solvents include toluene, xylene, cumene or mesitylene.
25 Toluene is most preferred. The base is a water soluble base.
Preferably, the base is an alkali metal base such as an alkali metal hydroxide or an alkali metal carbonate. Preferred alkali metals are sodium, potassium and lithium. An especially preferred alkali metal hydroxide is sodium hydroxide. Especially preferred alkali metal 30 carbonates are sodium carbonate and potassium carbonate.

CA 022~4~99 1998-11-27 Mo4699 - 3 -Preferably, the alkali metal base is provided as an aqueous solution containing from about 15 weight percent to about 50 weight percent of the base. More preferably, the aqueous solution contains from about 20 weight percent to about 30 weight percent base. The molar 5 ratio of base to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 1:1 to about 4:1.
The reaction mixture is maintained at a temperature of from about 15~C to about 50~C for a period of time sufficient for conversion of the acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The 10 time will vary with the reaction temperature. When the reaction temperature is about 25~C, the reaction is maintained at that temperature for from about 6 to about 18 hours.
In a preferred embodiment, a process of the invention includes the steps of mixing N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide 15 acetate in toluene with an aqueous solution of sodium hydroxide to form a reaction product having an aqueous phase and an organic phase, maintaining the reaction product at a temperature of about 25~C until the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetar"ide acetate is completely hydrolyzed. This elegant conversion can be monitored using 20 techniques such as gas chromatography (G.C.) or high pressure liquid chromatography (HPLC).
In another aspect, the present invention provides a process for converting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The 25 process includes the step of reacting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate with water in the presence of an aprotic, aromatic solvent.
The N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate used in the process is produced by reacting 2-chloro-N-(4-30 fluorophenyl)-N-(1-methylethyl)acetamide with sodium acetate. The CA 022~4~99 1998-11-27 Mo-4699 - 4 -reaction of the acetate with water in the solvent produces a reaction product having an aqueous phase and an organic phase. The process can further include the step of recovering N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide from the organic phase. Preferred solvents 5 include toluene, xylene, cumene or mesitylene. Toluene is most preferred.
The reaction mixture is maintained at a temperature of from about 15~C to about 50~C for a period of time sufficient for conversion of the acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide. The 10 time will vary with the reaction temperature. When the reaction temperature is about 25~C, the reaction is maintained at that temperature for about 40 hours.
In a preferred embodiment, the conversion process includes the steps of mixing N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetalr,ide 15 acetate in toluene with water to form a reaction product having an aqueous phase and an organic phase, maintaining the reaction product at a temperature of about 25~C until the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate disappears from the reaction product.
DETAILED DESCRIPTION OF THE INVENTION
20 I. The Invention This invention relates to processes for synthesizing N-(4-fluoro-phenyl)-2-hydroxy-N-(1 -methylethyl)aceta" ,ide (FOE-hydroxy). The processes provide for (a) converting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate (FOE-acetate) to N-(4-fluorophenyl)-2-25 hydroxy-N-(1-methylethyl)acetamide (FOE-hydroxy) using inorganic bases and (b) converting FOE-acetate to FOE-hydroxy using just water and an aprotic, aromatic solvent.

CA 022~4~99 1998-11-27 Mo4699 - 5 -Il. Conversion of N-(4-fluorophenYI)-2-hvdroxY-N-(1-methvlethyl)-acetamide acetate to N-(4-fluorophenvl)-2-hvdroxY-N-(1-methvlethyl)acetamide usin~ Aqueous Alkali In one aspect, the present invention provides a process for making 5 FOE-hydroxy whereby N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)-acetamide acetate (FOE-acetate) is converted to FOE-hydroxy. The conversion involves hydrolyzing the FOE-acetate with an aqueous alkali.
The acetate used in the process can be made by any means.
Preferably, however, the acetate is made by reacting FOE-chloride with 10 sodium acetate, with or without catalysts.
As set forth herein before, the reaction of sodium acetate and FOE-chloride with the subsequent hydrolysis of the FOE-acetate to FOE-hydroxy is an existing method for making FOE-hydroxy (See, e.g., U.S.
Patent 4,334,073, the disclosure of which is incorporated herein by 15 reference). In accordance with that method, hydrolysis of the FOE-acetate is accomplished with the use of an alcohol such as methanol.
The use of methanol, however, results in the formation of substantial amounts of the by-product, methyl acetate. This by-product must be removed from the reaction product using a distillation step. The present 20 process avoids the formation of the methyl acetate by-product and, thus, eliminates the distillation step.
A process of the present invention uses an aqueous alkali or base to hydrolyze the FOE-acetate intermediate. More particularly, the process includes the step of reacting FOE-acetate with an alkali metal 25 base in the presence of water and an appropriate organic solvent.
A preferred solvent for use in the process is an aprotic, aromatic organic solvent. Such solvents are well known in the art. Exemplary and preferred such solvents are toluene, xylene, cumene and mesitylene.
Toluene is most preferred. The molar ratio of solvent to FOE-acetate is 30 from about 4:1 to about 8:1.

CA 022~4~99 1998-11-27 Mo-4699 - 6 -The base used in the process is a water soluble base. Preferably, the base is an alkali metal base such as an alkali metal hydroxide or an alkali metal carbonate. Preferred alkali metals are sodium, potassium and lithium. An especially preferred alkali metal hydroxide is sodium 5 hydroxide. Especially preferred alkali metal carbonates are sodium carbonate and potassium carbonate.
Preferably, the alkali metal base is provided as an aqueous solution containing from about 15 weight percent to about 50 weight percent of the base. More preferably, the aqueous solution contains from 10 about 20 weight percent to about 30 weight percent base. The molar ratio of base to FOE-acetate is from about 1:1 to about 4:1.
The reaction is initiated by mixing the FOE-acetate in the solvent (e.g., toluene) with base and water. The reaction mixture, thus, contains both an aqueous phase and an organic phase. The total amount of base 15 can be added at a single time or, preferably, in aliquots over 1 to 2 hours. The molar ratio of added water to FOE-acetate is from about 25:1 to about 50:1.
The reaction mixture is heated until hydrolysis of the FOE-acetate is substantially complete. The total time needed for completion of the 20 reaction varies, as is well known in the art, with reaction temperature.
Typically, the reaction mixture is maintained at a temperature of from about 15~C to about 50~C. An especially preferred reaction temperature is room temperature (about 25~C). When the reaction temperature is about 25~C, the reaction is maintained at that temperature for from about 25 6 to about 18 hours (overnight).
The process can further include the step of recovering FOE-hydroxy from the organic phase. Means for recovering FOE-hydroxy are the same as set forth above in Section ll.
In a preferred embodiment, a process of the invention includes the 30 steps of mixing FOE-acetate in toluene with an aqueous solution of CA 022~4~99 1998-11-27 Mo-4699 - 7 -sodium hydroxide to form a reaction product having an aqueous phase and an organic phase, maintaining the reaction product at a temperature of about 25~C until the FOE-acetate is completely hydrolyzed, and recovering the FOE-hydroxy.
5 Ill. Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethYI)-acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide via HydrolYsis in Solvent and Water The present invention provides an additional means for converting FOE-acetate to FOE-hydroxy, which means avoids the use of both 10 methanol and aqueous alkali. In accordance with this process, FOE-acetate is hydrolyzed to FOE-hydroxy with water in the presence of solvent. The by-product is acetic acid, which is easily biodegradable resulting in no salt load of sodium acetate in the waste stream. Preferred solvents are the same as set forth above. Toluene is the most preferred~ 5 solvent.
Hydrolysis is carried out by dissolving or otherwise suspending FOE-acetate in the solvent. Preferred ratios of solvent to FOE-acetate are set forth above. The FOE-acetate in solvent is then mixed with water in the molar ratio of from about 5 to about 30 moles of water per mole of 20 FOE-acetate. Preferably, that molar ratio is from about 25:1 to about 30:1. The mixture of FOE-acetate, solvent and water is then maintained at a suitable temperature for hydrolysis for a period of time sufficient for hydrolysis of the FOE-acetate to FOE-hydroxy. The time required for substantially complete hydrolysis will vary, as is well known in the art, on 25 the hydrolysis temperature used. Typically, hydrolysis with water is carried out at a temperature of from about 20~C to about 50~C. More preferably, the temperature is from about 20~C to about 30~C. This temperature range corresponds to ambient, room temperature conditions.
When hydrolysis is carried out at ambient, room temperature, the time 30 required for substantially complete hydrolysis of the FOE-acetate is from CA 022~4~99 1998-11-27 Mo4699 - 8 -about 35 to about 45 hours. The progress of the hydrolysis reaction can be monitored using GC or HPLC analysis and terminated upon disappearance of FOE-acetate. FOE-hydroxy made in accordance with this hydrolysis is recovered and isolated using means well known in the art such as set forth above.
The Examples that follow illustrate preferred embodiments of the present invention and are not limiting of the specification and claims in any way.
EXAMPLES
10 Example 1:
Conversion of N-(4-fluoroPhenyl)-2-hvdroxv-N-(1-methYlethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide Usin~
Aqueous Alkali and Toluene 253.24 Grams (1.0 mole) of FOE-acetate were placed in a flask.
15 600 Grams of toluene were added with agitation to the flask at ambient temperature (25~C). 600 Grams of water were then added to the agitated mixture, followed by the addition of 160 Grams of 50% NaOH (2 moles).
The mixture was stirred at various temperatures (25~C to 80~C) for various times (4 to 10 hours).
G.C. analysis and HPLC analysis of the organic phase indicated completion of the reaction. The phases were separated and the aqueous phase washed with 100 Grams toluene. The toluene wash was combined with the organic phase. Solvent was removed via vacuum stripping and FOE-hydroxy was isolated via flaking. The results are summarized in the 25 table below.
Reaction Temp Reaction Time A.l. % NetYield %
25~C 10 hrs 98.2 97.5 40~C 8 hrs 98.0 97.4 60~C 6 hrs 97.8 96.2 80~C 4 hrs 96.6 95.5 CA 022~4~99 1998-11-27 Mo4699 - 9 -Example 2:
Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide Usin~
Water and Toluene 253.24 Grams (1.0 mole) of FOE-acetate were placed in a flask.
About 600 Grams of toluene were added with agitation at ambient temperature (25~C). About 600 Grams of water were then added to the agitated mixture at 25~C. The mixture was agitated at various temperatures (25~C-80~C) for various times (12-48 hours).
G.C. analysis and HPLC analysis of the organic phase indicated completion of the reaction (at 25~C, ca. 50% completion was observed at the end of 24 hrs). The phases were separated and the aqueous phase washed with 100 grams of toluene. The toluene wash was combined with the organic phase. Solvent was removed through vacuum stripping and 15 FOE-hydroxy isolated via flaking. The results are shown in the table below.
Reaction Temp Reaction Time A.l. % NetYield %
25~C 48 hrs 98.4 97.8 40~C 36 hrs 98.4 97.6 60~C 24 hrs 98.2 97.1 80~C 12 hrs 98.0 96.8 Although the invention has been described in detail in the foregoing for the purpose of illustration, it is be understood that such detail is solely for that purpose and that variations can be made therein 25 by those skilled in the art without departing from the spirit and scope of the invention except as it may be limited by the claims.

Claims (21)

1. A process for making N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide comprising the steps of:
(a) reacting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)-acetamide acetate with an alkali metal base in the presence of water and an aprotic, aromatic solvent to form a reaction product having an aqueous phase and an organic phase;
and (b) recovering N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)-acetamide from the organic phase.
2. The process of Claim 1 wherein the solvent is toluene, xylene, cumene or mesitylene.
3. The process of Claim 2 wherein the solvent is toluene.
4. The process of Claim 1 wherein the alkali metal base is an alkali metal hydroxide or an alkali metal carbonate.
5. The process of Claim 4 wherein the alkali metal is sodium, potassium or lithium.
6. The process of Claim 5 wherein the alkali metal hydroxide is sodium hydroxide.
7. The process of Claim 5 wherein the alkali metal carbonate is potassium carbonate.
8. The process of Claim 1 wherein the molar ratio of alkali metal base to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 1:1 to about 4:1.
9. The process of Claim 1 wherein the aqueous alkali metal base is an aqueous solution of from about 1 weight percent to about 50 weight percent alkali metal base.
10. The process of Claim 9 wherein the alkali metal base is sodium hydroxide.
11. The process of Claim 1 wherein N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate in toluene is mixed with an aqueous solution of sodium hydroxide to form a reaction product and the reaction product maintained at a temperature of from about 20°C to about 45°C until the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate disappears from the reaction product.
12. The process of Claim 1 wherein the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is formed by reacting 2-chloro-N-(4-fluorophenyl)-N-(1-methylethyl)acetamide with sodium acetate.
13. A process of converting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide comprising the step of hydrolyzing N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide acetate with water in the presence of an aprotic, aromatic solvent.
14. The process of Claim 13 wherein the solvent is toluene, cumene, xylene or mesitylene.
15. The process of Claim 14 wherein the solvent is toluene.
16. The process of Claim 15 wherein the molar ratio of toluene to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 3:1 to about 10:1.
17. The process of Claim 16 wherein the molar ratio of toluene to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 4:1 to about 5:1.
18. The process of Claim 13 wherein the molar ratio of water to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 10:1 to about 30:1.
19. The process of Claim 18 wherein the molar ratio of water to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate is from about 20:1 to about 30:1.
20. The process of Claim 13 wherein hydrolysis is carried out at a temperature of from about 20°C to about 30°C for from about 35 to about 45 hours.
21. A process of converting N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate to N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide comprising the steps of:
(a) adding water to a mixture of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide acetate in toluene to form a reaction mixture having an aqueous phase and an organic phase;
(b) heating the reaction mixture from step (a) to a temperature of from about 20°C to about 30°C for from about 35 hours to about 45 hours;
(c) separating the organic phase from the aqueous phase; and (d) recovering N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)-acetamide from the organic phase.
CA002254599A 1997-12-12 1998-11-27 Conversion of n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide acetate to n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide Abandoned CA2254599A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/989,151 US5808153A (en) 1997-12-12 1997-12-12 Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide acetate to N-4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide
US08/989,151 1997-12-12

Publications (1)

Publication Number Publication Date
CA2254599A1 true CA2254599A1 (en) 1999-06-12

Family

ID=25534814

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002254599A Abandoned CA2254599A1 (en) 1997-12-12 1998-11-27 Conversion of n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide acetate to n-(4-fluorophenyl)-2-hydroxy-n-(1-methylethyl)acetamide

Country Status (2)

Country Link
US (1) US5808153A (en)
CA (1) CA2254599A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540733B2 (en) * 2000-12-29 2003-04-01 Corazon Technologies, Inc. Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion
US7540852B2 (en) * 2004-08-26 2009-06-02 Flowcardia, Inc. Ultrasound catheter devices and methods
CN103254662A (en) * 2013-05-27 2013-08-21 道奇威(成都)科技有限公司 Organic surface modification method for preparing ultra-disperse rutile titanium dioxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2904490A1 (en) * 1979-02-07 1980-08-21 Bayer Ag METHOD FOR THE PRODUCTION OF ALPHA HYDROXYCARBONIC ACID AMIDES
DE3422861A1 (en) * 1984-06-20 1986-01-02 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING HETEROARYLOXYACETAMIDES

Also Published As

Publication number Publication date
US5808153A (en) 1998-09-15

Similar Documents

Publication Publication Date Title
US4977264A (en) Process for the production of 4,5-dichloro-6-ethylpyrimidine
RU2470919C2 (en) Method of producing toluidine compound
US5808153A (en) Conversion of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide acetate to N-4-fluorophenyl)-2-hydroxy-N-(1-methylethyl) acetamide
US7057068B2 (en) Process for the preparation of modafinil
KR20010072702A (en) Process for the preparation of fluorobenzyl derivatives
CA2083108A1 (en) Process for the production of .alpha.-hydroxy-.beta.-aminocarboxylic acids
MXPA98010187A (en) Conversion of n- (4-fluorophenyl) -2-hydroxy-n- (1-methylthyl) acetamide in n- (4-fluorophenyl) -2-hydroxy-n- (1-methylthyl) acetam
KR100330609B1 (en) Process for producing 3-isoxazolecarboxylic acid
US6605716B2 (en) Process for the preparation of hydroxy and amino compounds
KR100415520B1 (en) Process for Producing 1-(2-Chlorophenyl)-5(4H)-Tetrazolinone
US5808152A (en) Synthesis of N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide using sodium formate
CA1158249A (en) Preparation of 1h-pyrrol-2-acetic acid esters
CN111039838B (en) Preparation method of 3-acetylmercapto-2-methylpropanoic acid
KR100577874B1 (en) Preparing method for methyl 4-hydroxyiminovenzoate utilizing evaporated residue from DMT preparation
JPH07316137A (en) Production of (hexahydro-1-methyl-1h-azepin-4-yl)-hydrazine or salt thereof
KR910006981B1 (en) Process for the preparation of carboxylate chlorate roxatidine
KR980001999A (en) Di-3-methyl-cyclopentadecan-1-one
JPH0674245B2 (en) Method for producing sulfonium compound
JPH0627108B2 (en) Method for producing 4-carboxamide cyclohexanecarboxylic acid esters
JPH10139724A (en) Production of 4-biphenylylacetic acid
EP0657442A2 (en) Thiazole derivate and process for its preparation
JPH10338679A (en) Production of thiazolidine derivative
JPH0745468B2 (en) Process for producing tetrachlor-3-imino-isoindoline-1-one
JPS61122243A (en) Production of cycloalkanecarboxylic acid salt compound
JPH0558954A (en) Production of trifluorolactic acid derivative

Legal Events

Date Code Title Description
FZDE Discontinued